Clinical Trial Update: SIRONA Trial Heart Failure NYHA Class III [NA]

View source ↗

Summary

Endotronix's SIRONA trial for heart failure in NYHA Class III patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Endotronix, Inc. | Conditions: Heart Failure NYHA Class III | NA | Status: COMPLETED